SCHEMBL606435

SCHEMBL606435

Cc1ccc2c3ccccc3n(CC(O)CN3CCN(Cc4ccccc4)CC3)c2c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.80
GAA P10253 1/20 0.80
HTT P42858 4/20 0.65
MAPK1 P28482 3/20 0.65
MAPT P10636 4/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
POLB P06746 2/20 0.56
KDM4E B2RXH2 3/20 0.55
ALDH1A1 P00352 1/20 0.55
TP53 P04637 1/20 0.55
HPGD P15428 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ATM Q13315 1/20 0.54
RAD52 P43351 1/20 0.53
TSHR P16473 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
GRIN2D O15399 2/20 0.51
GRIN3B O60391 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL607881 0.89 LMNA (1.00) LMNAGAAHTTMAPK1MAPT
SCHEMBL607337 0.87 LMNA (0.81) LMNAGAAHTTMAPK1MAPT
SCHEMBL607619 0.83 LMNA (0.81) LMNAGAAHTTMAPK1MAPT
SCHEMBL607488 0.81 LMNA (0.82) LMNAGAAHTTMAPK1MAPT
SCHEMBL6815269 0.80 POLB (0.84) LMNAGAAHTTMAPK1MAPT
SCHEMBL608283 0.80 LMNA (0.81) LMNAGAAHTTMAPK1MAPT
SCHEMBL609395 0.79 LMNA (0.75) LMNAGAAHTTMAPK1MAPT
SCHEMBL607474 0.79 LMNA (1.00) LMNAGAAHTTMAPK1MAPT
SCHEMBL617611 0.79 LMNA (0.75) LMNAGAAHTTMAPK1MAPT
SCHEMBL609435 0.79 LMNA (0.75) LMNAGAAHTTMAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1237887-B1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS SERONO LAB (CH) 2008-06-04 EP claimed
EP-1094063-A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators Applied Research Systems ARS Holding N.V. (AN) 2001-04-25 EP claimed
US-8410110-B2 9-(piperazinylalkyl) carbazoles as Bax-modulators MERCK SERONO SA (CH) 2013-04-02 US disclosed
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2012-02-16 US disclosed
US-8053436-B1 9-(piperazinylalkyl) carbazoles as bax-modulators MERCK SERONO SA (CH) 2011-11-08 US disclosed
EP-1237887-B1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS SERONO LAB (CH) 2008-06-04 EP disclosed
EP-1237887-A1 9-(PIPERAZINYLALKYL)CARBAZOLES AS BAX-MODULATORS Applied Research Systems ARS Holding N.V. (AN) 2002-09-11 EP disclosed
WO-2001029028-A1 9- (PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-26 WO disclosed
EP-1094063-A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators Applied Research Systems ARS Holding N.V. (AN) 2001-04-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040933-A1 9-(PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS BCL2, BAX, BAD LMNA 55/4885GAA 926/4885HTT 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.